HUTCHMED (LON:HCM) Stock Price Crosses Above 200 Day Moving Average – What’s Next?

Shares of HUTCHMED (China) Limited (LON:HCM) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 232.68 and traded as high as GBX 235. HUTCHMED shares last traded at GBX 232, with a volume of 22,640 shares.

HUTCHMED Stock Down 3.4%

The stock’s fifty day moving average price is GBX 233.39 and its 200 day moving average price is GBX 232.68. The company has a current ratio of 2.81, a quick ratio of 2.97 and a debt-to-equity ratio of 11.97. The stock has a market cap of £1.92 billion, a P/E ratio of 4.23 and a beta of 0.76.

About HUTCHMED

We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S.

We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China.

HUTCHMED is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange’s AIM market (Nasdaq/AIM:HCM; HKEX:13).